Keyword: Drug and Chemical Associated Technologies Association (DCAT)
News
29.03.2017
- AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...
News
29.03.2017
- The US Third Circuit Court of Appeals in Philadelphia, Pennsylvania, has ruled that 5,000 lawsuits brought by patients taking Merck & Co.’s osteoporosis drug Fosamax (alendronate)...
News
14.03.2017
- US President Donald Trump has chosen Scott Gottlieb to head the Food and Drug Administration. The 44-year-old former physician, who served as deputy FDA commissioner of medical and...
News
09.03.2017
- The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...
News
06.03.2017
- Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...
News
01.03.2017
- In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...
News
20.02.2017
- US drugs giant Pfizer has challenged the record £84 million fine imposed by the UK’s Competition and Markets Authority (CMA) for a supply scheme that resulted in a 2,600% price...
News
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
